Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3750
+0.0050 (1.35%)
Feb 19, 2026, 4:10 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 109.06 million as of February 18, 2026. Its market cap has increased by 275.18% in one year.
Market Cap
109.06M
Enterprise Value
101.81M
Revenue
118.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 109.06M, an increase of 156.57%. That is a compound annual growth rate of 21.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 109.06M | -5.73% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | 42.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 173.51M |
| Actinogen Medical | 145.40M |
| Paradigm Biopharmaceuticals | 132.30M |
| Arovella Therapeutics | 112.08M |
| LTR Pharma | 94.52M |
| Alterity Therapeutics | 92.44M |
| Cynata Therapeutics | 87.03M |
| Imugene | 81.99M |